关注
Dmitry Gabrilovich
Dmitry Gabrilovich
Chief Scientist, Cancer Immunology, AstraZeneca
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Myeloid-derived suppressor cells as regulators of the immune system
DI Gabrilovich, S Nagaraj
Nature reviews immunology 9 (3), 162-174, 2009
75502009
Understanding the tumor immune microenvironment (TIME) for effective therapy
M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ...
Nature medicine 24 (5), 541-550, 2018
41322018
Coordinated regulation of myeloid cells by tumours
DI Gabrilovich, S Ostrand-Rosenberg, V Bronte
Nature Reviews Immunology 12 (4), 253-268, 2012
38382012
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
DI Gabrilovich, HL Chen, KR Girgis, HT Cunningham, GM Meny, S Nadaf, ...
Nature medicine 2 (10), 1096-1103, 1996
30681996
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ...
Nature communications 7 (1), 12150, 2016
25062016
Immunosuppressive strategies that are mediated by tumor cells
GA Rabinovich, D Gabrilovich, EM Sotomayor
Annu. Rev. Immunol. 25, 267-296, 2007
20892007
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
JI Youn, S Nagaraj, M Collazo, DI Gabrilovich
The Journal of Immunology 181 (8), 5791-5802, 2008
20442008
The nature of myeloid-derived suppressor cells in the tumor microenvironment
V Kumar, S Patel, E Tcyganov, DI Gabrilovich
Trends in immunology 37 (3), 208-220, 2016
19012016
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer
B Almand, JI Clark, E Nikitina, J van Beynen, NR English, SC Knight, ...
The Journal of Immunology 166 (1), 678-689, 2001
17352001
Myeloid-derived suppressor cells
DI Gabrilovich
Cancer immunology research 5 (1), 3-8, 2017
16392017
Myeloid-derived suppressor cells coming of age
F Veglia, M Perego, D Gabrilovich
Nature immunology 19 (2), 108-119, 2018
15652018
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
T Wang, G Niu, M Kortylewski, L Burdelya, K Shain, S Zhang, ...
Nature medicine 10 (1), 48-54, 2004
14512004
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
S Nagaraj, K Gupta, V Pisarev, L Kinarsky, S Sherman, L Kang, ...
Nature medicine 13 (7), 828-835, 2007
13742007
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
Nature Reviews Immunology 4 (12), 941-952, 2004
13712004
History of myeloid-derived suppressor cells
JE Talmadge, DI Gabrilovich
Nature Reviews Cancer 13 (10), 739-752, 2013
13112013
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo …
D Gabrilovich, T Ishida, T Oyama, S Ran, V Kravtsov, S Nadaf, ...
Blood, The Journal of the American Society of Hematology 92 (11), 4150-4166, 1998
12641998
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
CA Corzo, T Condamine, L Lu, MJ Cotter, JI Youn, P Cheng, HI Cho, ...
Journal of Experimental Medicine 207 (11), 2439-2453, 2010
12402010
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
D Marvel, DI Gabrilovich
The Journal of clinical investigation 125 (9), 3356-3364, 2015
10882015
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
P Cheng, CA Corzo, N Luetteke, B Yu, S Nagaraj, MM Bui, M Ortiz, ...
The Journal of experimental medicine 205 (10), 2235-2249, 2008
10682008
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev, Y Nefedova, D Yoder, DI Gabrilovich
The Journal of Immunology 172 (2), 989-999, 2004
10382004
系统目前无法执行此操作,请稍后再试。
文章 1–20